Imatinib in Adult Patients With Metastatic Ocular Melanoma (O-Mel-Inib)
This study has been terminated.
(Study stopped at the end of the first step)
Sponsor:
Centre Oscar Lambret
Collaborators:
Novartis
National Cancer Institute, France
Information provided by (Responsible Party):
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT00421317
First received: January 9, 2007
Last updated: August 10, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |